Evidence map›Paper›PMID 40124067›Full record

ReviewACS omega2025

Next-Generation Metal-Organic Frameworks: Shaping the Future of Steroid Compound Management.

Haidong Jiang, Siyan Xu, Xiaomeng Xiang, Mengfan Zhao, Ying Wang, Xiangyu Liu, Bing Liu, Qing Chen

Abstract readReview
In one paragraph

Review in ACS omega, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Haidong JiangShanghai University of Sport, 399 Changhai Road, Shanghai 200438, China.
Siyan XuShanghai University of Sport, 399 Changhai Road, Shanghai 200438, China.
Xiaomeng XiangShanghai University of Sport, 399 Changhai Road, Shanghai 200438, China.
Mengfan ZhaoDepartment of Pharmacy, Shenyang Medical College, Shenyang 110034, China.
Ying WangDepartment of Pharmacy, Shenyang Medical College, Shenyang 110034, China.
Xiangyu LiuDepartment of Pharmacy, Shenyang Medical College, Shenyang 110034, China.
Bing LiuShanghai University of Sport, 399 Changhai Road, Shanghai 200438, China.ORCID https://orcid.org/0000-0002-6337-3774
Qing ChenDepartment of Pharmacy, Shenyang Medical College, Shenyang 110034, China.ORCID https://orcid.org/0000-0001-6251-8292

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Metal-Organic Frameworks (MOFs), as a new type of porous material, have attracted widespread attention in the fields of chemistry, materials science, and biomedicine owing to their unique structural characteristics and potential for functionalization. This review summarizes the latest research progress of MOFs in the field of steroid compounds, including the latest research progress of MOFs in the purification and separation of steroids, sensing and detection, catalytic transformation, and drug delivery. First, we explore how the porous structure and chemical functionalization of MOFs achieve efficient separation and purification of steroid compounds. Second, the high sensitivity and selectivity of MOFs as sensing materials in steroid detection, as well as their application potential in actual sample analysis, are analyzed. Furthermore, the role of MOFs in steroid catalytic transformation reactions is discussed, including their performance as catalysts or catalyst carriers. Finally, we focus on the innovative applications of MOFs in drug delivery systems, especially their advantages in controlled release and targeted drug delivery. This article also explores the future development trends and application prospects of MOFs in the field of steroids, highlighting the challenges and opportunities in material design, functionalization strategies, and practical implementations. Through this review, we aim to provide a comprehensive theoretical basis and practical guidance for further research and application of MOFs in the field of steroids.

Identifiers

PMID40124067
PMCPMC11923678

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.